Notably, key tumor suppressor genes like TP53 exhibited significant differences in mutation patterns across different risk groups, these findings unveiling the molecular heterogeneity of ICD-related gene mutations in HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.